A hybrid in silico approach reveals novel inhibitors of multiple SARS-CoV-2 variants
S. Jain, D. C. Talley, B. Baljinnyam…·A. V. Zakharov
The paper uses a hybrid in silico approach combining machine learning and pharmacophore modeling on NCATS screening data to identify novel inhibitors effective against multiple SARS-CoV-2 variants.